Brennan Spiegel, MD, MSHS

Articles by Brennan Spiegel, MD, MSHS

Cost-Effectiveness of Pharmacist Postdischarge Follow-Up to Prevent Medication-Related Admissions

ByBrennan Spiegel, MD, MSHS,Rita Shane, PharmD,Katherine Palmer, PharmD,Duong Donna Luong, PharmD

June 18th 2018

A multivariable sensitivity analysis conducted on a pharmacy follow-up program of high-risk patients demonstrated cost savings to hospitals in 98.3% of head-to-head trials across 1000 hypothetical hospitals.

Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?

ByTimothy J. Daskivich, MD, MSHPM,Garen Abedi, MD, MS,Sherrie H. Kaplan, PhD, MPH,Douglas Skarecky, BS,Thomas Ahlering, MD,Brennan Spiegel, MD, MSHS,Mark S. Litwin, MD, MPH,Sheldon Greenfield, MD

January 18th 2018

Electronic health record (EHR)-based comorbidity assessment had low sensitivity for identifying major comorbidities and poorly predicted survival. EHR-based comorbidity data require validation prior to application to risk adjustment.

Latest Updated Articles

Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?
January 18th 2018
Cost-Effectiveness of Pharmacist Postdischarge Follow-Up to Prevent Medication-Related Admissions
June 18th 2018

Brennan Spiegel, MD, MSHS

Articles by Brennan Spiegel, MD, MSHS

Cost-Effectiveness of Pharmacist Postdischarge Follow-Up to Prevent Medication-Related Admissions

Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?

Latest Updated Articles

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD